LIGAND PHARMACEUTICALS INC - 8-K Filing
Ligand Pharmaceuticals completed its $39/share acquisition of XOMA Royalty on July 14, 2026 and entered a new $125M credit facility. (Items: 1.01 Entry into a Material Definitive Agreement, 2.01 Completion of Acquisition or Disposition of Assets, 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, 7.01 Regulation FD Disclosure)
Tickers: $LGND